What this study adds
We evaluated the pharmacokinetics of propranolol in 54 patients with
cirrhosis, compared with 30 healthy individuals and 18 patients with
chronic active hepatitis.
The systemic exposure of propranolol was affected by H/L ratio and
several laboratory tests.
We proposed the prediction model for propranolol systemic exposure using
those affecting elements.